|
|
|
|
|
|
|
|
|
|
|
|
|
| Dockets Entered
On September 3, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1995S-0316
|
| 75-Day Premarket Notifications
for New Dietary Ingredients
|
|
|
| 2002D-0320
|
| Hold following clinical
investigator misconduct
|
|
|
| 2003H-0432
|
| Civil Money Penalty,
Korangy Radiology Associates, PA
|
|
|
| 2003N-0455
|
| Training Program for
Regulatory Project Managers; Information Available to Industry
|
|
|
| 2003Q-0401
|
| Qualified Health Claim
(QHC) Omega-3 Fatty Acids and Coronoary Heart Disease Health Claim
|
|
|
| 2004E-0397
|
| Patent Extension for
Prilosec OTC (omeprazole magnesium), U.S. Patent No. 5,817,338
|
|
|
| 2004E-0398
|
| Patent Extension for
IRESSA (gefitinib), U.S. Patent No. 5,770,599
|
|
|
| 2004E-0399
|
| Patent Extension for
Sensipar (cinacelet hydrochloride), U.S. Patent No. 6,313,146
|
|
|
| 2004E-0402
|
| Patent Extension for
AVASTIN (bevacizumab), U.S. Patent No. 6,054,297
|
|
|
| 2004M-0387
|
| P030010 - Siemens Mammomat
Novation Full Field Digital Mammography System,
|
|
|
| 2004M-0388
|
| P040012 - ACCULINK Carotid
Stent System and RX ACCULIN Carotid Stent System
|
|
|
| 2004N-0214
|
| Public Information Regulations
|
|
|
| 2004N-0330
|
| Suicidality in Clinical Trials
for Antidepressant Drugs in Pediatric Patients
|
|
| 2004P-0365
|
| Refrain from approving
ANDA for Agrylin (anagrelide hydrochloride) Capsules
|
|
|
| 2004V-0400
|
| Laser Light Show
|
|
|
| 1995S-0316
|
| 75-Day Premarket
Notifications for New Dietary Ingredients
|
|
| RPT
225
|
| Rocky Mountain Selenium,
Inc
|
| Vol #:
|
| 163
|
|
|
| RPT
226
|
| Altai, LLC
|
| Vol #:
|
| 163
|
|
|
| RPT
227
|
| Outsource Product Manufacture
LLC
|
| Vol #:
|
| 163
|
|
|
| RPT
228
|
| Bioriginal Food &
Science Corporation
|
| Vol #:
|
| 164
|
|
|
| RPT
229
|
| Conseco Sea Buckthorn
Co., Ltd
|
| Vol #:
|
| 163
|
|
|
| RPT
230
|
| Conseco Sea Buckthorn
Co., Ltd
|
| Vol #:
|
| 163
|
|
|
| RPT
231
|
| Seven Tortoise Co.,
Ltd
|
| Vol #:
|
| 163
|
|
|
| RPT
232
|
| Omega Bio-Pharma (USA)
LLC
|
| Vol #:
|
| 163
|
|
|
| 2002D-0320
|
| Hold following clinical
investigator misconduct
|
|
|
| GDL
2
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2003H-0432
|
| Civil Money Penalty,
Korangy Radiology Associates, PA
|
|
|
| CS
8
|
| HFA-305 to Henry E.
Schwartz LLC
|
| Vol #:
|
| 4
|
|
|
| OR
7
|
| HF-3
|
| Vol #:
|
| 4
|
|
|
| 2003N-0455
|
| Training Program
for Regulatory Project Managers; Information Available to Industry
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2003Q-0401
|
| Qualified Health
Claim (QHC) Omega-3 Fatty Acids and Coronoary Heart Disease Health Claim
|
|
|
| C
8
|
| Unilever United States,
Inc.
|
| Vol #:
|
| 2
|
|
| | | | | | | | |
|
|
| LET
9
|
| American Longevity Inc & Life Extension Foundation Buyers Club Inc
|
| Vol #:
|
| 2
|
|
|
| LET
10
|
| Martek Biosciences Corporation (Martek)
|
| Vol #:
|
| 2
|
|
|
| 2004E-0397
|
| Patent Extension for Prilosec OTC (omeprazole magnesium), U.S. Patent No. 5,817,338
|
|
|
| APP
1
|
| AstraZeneca AB
|
| Vol #:
|
| 1
|
|
|
| LET
1
|
| U.S. Patent & Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2004E-0398
|
| Patent Extension for IRESSA (gefitinib), U.S. Patent No. 5,770,599
|
|
|
| APP
1
|
| AstraZeneca UK Limited
|
| Vol #:
|
| 1
|
|
|
| LET
1
|
| U.S. Patent & Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2004E-0399
|
| Patent Extension for Sensipar (cinacelet hydrochloride), U.S. Patent No. 6,313,146
|
|
|
| APP
1
|
| NPS Pharmaceuticals Inc. & The Brigham and Women's Hospital
|
| Vol #:
|
| 1
|
|
|
| LET
1
|
| U.S. Patent & Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2004E-0402
|
| Patent Extension for AVASTIN (bevacizumab), U.S. Patent No. 6,054,297
|
|
|
| APP
1
|
| Genentech, Inc.
|
| Vol #:
|
| 1
|
|
|
| LET
1
|
| U.S. Patent & Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2004M-0387
|
| P030010 - Siemens Mammomat Novation Full Field Digital Mammography System,
|
|
|
| AAV
1
|
| Siemens Medical Solutions USA, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004M-0388
|
| P040012 - ACCULINK Carotid Stent System and RX ACCULIN Carotid Stent System
|
|
|
| AAV
1
|
| Guidant Corporation
|
| Vol #:
|
| 1
|
|
|
| 2004N-0214
|
| Public Information Regulations
|
|
|
| NFR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| NPR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0330
|
| Suicidality in Clinical Trials for Antidepressant Drugs in Pediatric Patients
|
|
|
| EC 19
|
| Cardiff University
|
| Vol #:
|
| 1
|
|
|
| EC 20
|
| Cardiff University
|
| Vol #:
|
| 1
|
|
|
| EC 21
|
| Dr. Molly Hauck
|
| Vol #:
|
| 1
|
|
|
| 2004P-0365
|
| Refrain from approving ANDA for Agrylin (anagrelide hydrochloride) Capsules
|
|
|
| PSA
1
|
| Shire US, Inc.
|
| Vol #:
|
| 2
|
|
|
| 2004V-0400
|
| Laser Light Show
|
|
|
| ACK 1
|
| HFA-305 to Travis Hopkins
|
| Vol #:
|
| 1
|
|
|
| VAR
1
|
| Travis Hopkins
|
| Vol #:
|
| 1
|
|